Numerous Novel Therapeutics for Lupus Nephritis Under Investigation
The landscape of lupus nephritis treatment is poised to change in coming years.
The landscape of lupus nephritis treatment is poised to change in coming years.
Even people with HIV that is well controlled with viral suppression are at increased risk for acute kidney injury.
A majority of patients with hyperuricemia had NAFLD, investigators reported.
Investigators compared ADT plus abiraterone or docetaxel with ADT alone.
Major effects of febuxostat on renal outcome might be uric acid dependent, according to investigators.
Incorporating a combination of urinary biomarkers may help identify patients at the highest risk for CKD progression.
Investigators reviewed the latest studies examining the association between BCG administration and the risk of Alzheimer disease and other dementia in patients with bladder cancer.
Trajectories of key clinical variables associated with weight loss distinguished patients with physiologic resilience vs vulnerability.
Inorganic nitrate also reduced the risk for major adverse cardiac events in patients undergoing coronary angiography for non-ST-elevation acute coronary syndrome.
Treatment with the glucagon-like-peptide-1 receptor agonist yielded substantial benefits in patients with heart failure with preserved ejection fraction.